SEOUL, SOUTH KOREA, AND RIJSWIJK, THE NETHERLANDS –Celemics, provider of NGS target enrichment kits and innovative sequencing platforms, announced today the release of a comprehensive NGS target enrichment workflow for clinical and translational research applications. To serve as an end-to-end workflow with integrated genomic data analysis, Celemics partnered with BlueBee, an industrial-grade and highly configurable […]
NEW YORK — Gencove, the leading low-pass genome sequencing technology provider, announced today the launch of the first enterprise-ready low-pass sequencing analysis platform. The new cloud-based solution for imputation and downstream analytics of low-pass sequencing data is an important step forward in expanding the access to this technology. Gencove’s low-pass sequencing is a high-throughput, cost-efficient solution […]
Rijswijk, The Netherlands – BlueBee, a global bioinformatics solutions provider, has extended data operations to mainland China to serve genomic data processing needs in compliance with The Chinese Ministry of Health and Technology. This strategic move will serve existing and new BlueBee customers who integrate bioinformatic data solutions with their analytical instruments, omics assay technology or […]
Aligned with newly issued FDA Draft Guidance, Phoenix supports electronic data, methods and results audit, traceability and communication requirements PRINCETON, NJ – Certara®, the global model-informed drug development and decision support leader, today announced the launch of Phoenix® 8.2, the industry gold standard in pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation software for drug development. Phoenix is the […]
Genedata Biologics to accelerate antibody discovery and streamline R&D operations at Finland’s largest biopharma company Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced Orion Pharma, a globally operating Finnish pharmaceutical company, has licensed Genedata Biologics® to support their R&D in the areas of oncology, the central nervous […]
El Segundo, CA – BioDiscovery, Inc., a leader in innovative genomic software solutions, announced that Children’s Hospital of Los Angeles (CHLA), an award-winning hospital with comprehensive medical care services and programs for children, has signed on as a BioDiscovery Center of Excellence for Clinical Genomics to serve as a reference site for others seeking information […]
COLUMBUS, Ohio–As concerns about Americans’ exposure to a certain group of chemical substances continues to grow, Battelle researchers have added another tool in their suite to help assess and understand occurrence. Known as per- and polyfluoroalkyl substances (PFAS), PFAS are chemicals that have been used for decades in products that repel stains, water, grease, and oil and in firefighting […]
BC Platforms, a world leader in genomic data management and analytics, today announced that it has formed a collaboration with Debiopharm, a Swiss pharmaceutical company, to deliver a complete clinical and genomic data management solution to support its innovative oncology pipeline, including investigational product programs for Debio 0123 (Selective WEE1 inhibitor), diagnostic molecular screening for […]
OAKLAND, Calif.–Clinical genomic testing and next-generation sequencing (NGS) are integral parts of realizing the potential of precision medicine, but the data complexity and technical integrations needed to make genomic data clinically meaningful and routinized have slowed mainstream adoption of these breakthrough technologies. Today, Fabric Genomics, a global leader in clinical interpretation of genomic data, announced […]
Simulations Plus today announced a new funded collaboration with a clinical-stage biotech to develop an intra-articular delivery model in GastroPlus. New intra-articular injection route will expand the suite of drug delivery options available in GastroPlus® Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
